Core Insights - Stereotaxis has been recognized by NVIDIA at the GTC conference and accepted into the NVIDIA Connect program, which will enhance its technological capabilities in surgical robotics [1][2]. Company Overview - Stereotaxis is a leader in surgical robotics for minimally invasive endovascular interventions, with its technology used in over 100 hospitals globally, treating more than 150,000 patients [3][4]. - The company is focusing on advancing its robotic systems through digital solutions that incorporate AI, robotic automation, data integration, and decision support capabilities [3]. Industry Context - The NVIDIA GTC conference, attended by over 25,000 participants, emphasizes the integration of AI in various applications, including healthcare and surgical robotics [2]. - The collaboration with NVIDIA is expected to significantly enhance the precision, safety, and stability of Stereotaxis' robotic systems, potentially transforming patient treatment [4].